72 related articles for article (PubMed ID: 38627584)
1. Structure, Activity and Function of the MLL2 (KMT2B) Protein Lysine Methyltransferase.
Klonou A; Chlamydas S; Piperi C
Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440566
[TBL] [Abstract][Full Text] [Related]
2. The Histone H3 Lysine 4 Presenter WDR5 as an Oncogenic Protein and Novel Epigenetic Target in Cancer.
Lu K; Tao H; Si X; Chen Q
Front Oncol; 2018; 8():502. PubMed ID: 30488017
[TBL] [Abstract][Full Text] [Related]
3. The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer.
Pai CP; Wang H; Seachrist DD; Agarwal N; Adams JA; Liu Z; Keri RA; Cao K; Schiemann WP; Kao HY
Cell Death Differ; 2024 Apr; ():. PubMed ID: 38627584
[TBL] [Abstract][Full Text] [Related]
4. The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer.
Kao HY; Pai CP; Wang H; Agarwal N; Adams J; Liu Z; Seachrist D; Keri R; Schiemann W
Res Sq; 2023 Sep; ():. PubMed ID: 37720048
[TBL] [Abstract][Full Text] [Related]
5. GRWD1-WDR5-MLL2 Epigenetic Complex Mediates H3K4me3 Mark and Is Essential for Kaposi's Sarcoma-Associated Herpesvirus-Induced Cellular Transformation.
Wei S; Lu S; Liang L; Wang X; Li W; Li T; Chen L; Ju E; Zhang X; Lai Z; Huang Y; Lu X; Gao SJ
mBio; 2021 Dec; 12(6):e0343121. PubMed ID: 34933446
[TBL] [Abstract][Full Text] [Related]
6. Pax6 associates with H3K4-specific histone methyltransferases Mll1, Mll2, and Set1a and regulates H3K4 methylation at promoters and enhancers.
Sun J; Zhao Y; McGreal R; Cohen-Tayar Y; Rockowitz S; Wilczek C; Ashery-Padan R; Shechter D; Zheng D; Cvekl A
Epigenetics Chromatin; 2016; 9(1):37. PubMed ID: 27617035
[TBL] [Abstract][Full Text] [Related]
7. Porcine promyelocytic leukemia protein isoforms suppress Japanese encephalitis virus replication in PK15 cells.
Chen Z; Liu H; Zhu J; Duan X; Wang H; Li X; Zhou X; Zhao A; Yang S
Virol J; 2023 Nov; 20(1):280. PubMed ID: 38031162
[TBL] [Abstract][Full Text] [Related]
8. WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma.
Mitchell K; Sprowls SA; Arora S; Shakya S; Silver DJ; Goins CM; Wallace L; Roversi G; Schafer RE; Kay K; Miller TE; Lauko A; Bassett J; Kashyap A; D'Amato Kass J; Mulkearns-Hubert EE; Johnson S; Alvarado J; Rich JN; Holland EC; Paddison PJ; Patel AP; Stauffer SR; Hubert CG; Lathia JD
Genes Dev; 2023 Feb; 37(3-4):86-102. PubMed ID: 36732025
[TBL] [Abstract][Full Text] [Related]
9. MYC and therapy resistance in cancer: risks and opportunities.
Donati G; Amati B
Mol Oncol; 2022 Nov; 16(21):3828-3854. PubMed ID: 36214609
[TBL] [Abstract][Full Text] [Related]
10. SNAI1-mediated transcriptional regulation of epithelial-to-mesenchymal transition genes in breast cancer stem cells.
Singh D; Deshmukh RK; Das A
Cell Signal; 2021 Nov; 87():110151. PubMed ID: 34537302
[TBL] [Abstract][Full Text] [Related]
11. A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.
Patra U; Müller S
Front Cell Dev Biol; 2021; 9():696234. PubMed ID: 34513832
[TBL] [Abstract][Full Text] [Related]
12. PML nuclear bodies and chromatin dynamics: catch me if you can!
Corpet A; Kleijwegt C; Roubille S; Juillard F; Jacquet K; Texier P; Lomonte P
Nucleic Acids Res; 2020 Dec; 48(21):11890-11912. PubMed ID: 33068409
[TBL] [Abstract][Full Text] [Related]
13. The promyelocytic leukemia protein isoform PML1 is an oncoprotein and a direct target of the antioxidant sulforaphane (SFN).
Alhazmi N; Pai CP; Albaqami A; Wang H; Zhao X; Chen M; Hu P; Guo S; Starost K; Hajihassani O; Miyagi M; Kao HY
Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118707. PubMed ID: 32243901
[TBL] [Abstract][Full Text] [Related]
14. Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core.
Tian J; Teuscher KB; Aho ER; Alvarado JR; Mills JJ; Meyers KM; Gogliotti RD; Han C; Macdonald JD; Sai J; Shaw JG; Sensintaffar JL; Zhao B; Rietz TA; Thomas LR; Payne WG; Moore WJ; Stott GM; Kondo J; Inoue M; Coffey RJ; Tansey WP; Stauffer SR; Lee T; Fesik SW
J Med Chem; 2020 Jan; 63(2):656-675. PubMed ID: 31858797
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]